Dyadic International (DYAI) Receivables - Net (2017 - 2026)
Dyadic International's (DYAI) quarterly Receivables - Net came in at $996464.0 in Q1 2026, up 349.43% year-over-year from $221719.0 in Q1 2025, and down 8.61% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Dyadic International (DYAI) Receivables - Net (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Receivables - Net across 10 years of filings, most recently posting $996464.0 for Q1 2026.
- In Q1 2026, Receivables - Net rose 349.43% year-over-year to $996464.0; the TTM figure through Mar 2026 stood at $996464.0 (up 349.43% YoY), while the FY2025 annual figure was $1.1 million, up 359.99% from the prior year.
- Receivables - Net came in at $996464.0 for Q1 2026 at Dyadic International, down from $1.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $528.2 million in Q1 2022 to a low of $121000.0 in Q4 2022.
- Average Receivables - Net over 5 years is $31.6 million, with a median of $417878.0 recorded in 2023.
- Year-over-year, Receivables - Net jumped 137095.26% in 2022 and tumbled 99.86% in 2023.
- Over 5 years, Receivables - Net stood at $121000.0 in 2022, then soared by 76.03% to $213000.0 in 2023, then rose by 11.28% to $237027.0 in 2024, then jumped by 359.99% to $1.1 million in 2025, then retreated by 8.61% to $996464.0 in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $996464.0 in Q1 2026, $1.1 million in Q4 2025, and $916574.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn |
| 10 | Dyadic International | 17.65 Mn | 9.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 996,464.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 916,574.00 |
| Jun 30, 2025 | 715,317.00 |
| Mar 31, 2025 | 221,719.00 |
| Dec 31, 2024 | 237,027.00 |
| Sep 30, 2024 | 352,934.00 |
| Jun 30, 2024 | 249,806.00 |
| Mar 31, 2024 | 246,138.00 |
| Dec 31, 2023 | 213,000.00 |
| Sep 30, 2023 | 417,878.00 |
| Jun 30, 2023 | 767,597.00 |
| Mar 31, 2023 | 754,098.00 |
| Dec 31, 2022 | 121,000.00 |
| Sep 30, 2022 | 235,368.00 |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 528.15 Mn |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 180,000.00 |
| Jun 30, 2021 | 291,435.00 |